Glaxosmithkline Philippines, Inc.
cosmetic surgeryDescription
As on of the world’s leading research-based pharmaceutical and healthcare companies, GlaxoSmithKline (GSK) is committed to improving the quality of human life by enabling people to do more, feel better and live longer. With over 100,000 people in 116 countries, GSK has a wide range of pharmaceutical products to address many of the world’s healthcare needs and is the market leader in the market leader in the following therapeutic areas: respiratory, anti-infectives, central nervous system, alimentary, and metabolic diseases and vaccines. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines and oral care products which are among the market leaders. GSK continues to invest in health and education programmes and partnerships that aim to bring sustainable improvements to understand communities.
Address
Our Address:
2266 Chino Roces Ave., Makati City
Email address:
Web:
Island:
Luzon
Site:
Makati City
Province:
Metro Manila
Province PSGC:
137500000
Region Name:
National Capital Region
Region PSGC:
---
Municipality Name:
Makati City
Municipality PSGC:
137602000
Country:
Philippines
Postcode:
1231
Phone number:
+(632) 8920761
Contact Person:
Mailyn Ocampo
Contact Title:
Legal & External Affairs Director
Contact2:
---
Contact2 Title:
---
Barangay Name:
---
Barangay PSGC:
---
Health Facility Code:
---
Health Facility Code Short:
---
Ownership Major Classification:
Glaxosmithkline Philippines, Inc.
Ownership Sub Classification for Government Facilities:
---
Description
As on of the world’s leading research-based pharmaceutical and healthcare companies, GlaxoSmithKline (GSK) is committed to improving the quality of human life by enabling people to do more, feel better and live longer. With over 100,000 people in 116 countries, GSK has a wide range of pharmaceutical products to address many of the world’s healthcare needs and is the market leader in the market leader in the following therapeutic areas: respiratory, anti-infectives, central nervous system, alimentary, and metabolic diseases and vaccines. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines and oral care products which are among the market leaders. GSK continues to invest in health and education programmes and partnerships that aim to bring sustainable improvements to understand communities.